Taxol News and Research

RSS
Taxol is a drug used to treat breast cancer, ovarian cancer, and AIDS-related Kaposi sarcoma. It is also used together with another drug to treat non-small cell lung cancer. Taxol is also being studied in the treatment of other types of cancer. It blocks cell growth by stopping cell division and may kill cancer cells. It is a type of antimitotic agent. Also called paclitaxel.
Rice University researchers confirm potent synthesis of natural tetracycline

Rice University researchers confirm potent synthesis of natural tetracycline

SLU researchers discover pain pathway and potential way to block it

SLU researchers discover pain pathway and potential way to block it

Analysis of key cellular protein demonstrates the effectiveness of Taxol anti-cancer drug

Analysis of key cellular protein demonstrates the effectiveness of Taxol anti-cancer drug

Sorrento Therapeutics prices underwritten public offering of 4,765,000 shares of common stock

Sorrento Therapeutics prices underwritten public offering of 4,765,000 shares of common stock

Penn researchers use mathematical modeling to better understand mechanisms in TBI

Penn researchers use mathematical modeling to better understand mechanisms in TBI

Study shows how changes in organized cell membrane network of heart muscle leads to heart failure

Study shows how changes in organized cell membrane network of heart muscle leads to heart failure

Ajoene in garlic prevents bacteria from destroying white blood cells

Ajoene in garlic prevents bacteria from destroying white blood cells

Cell Therapeutics completes patient enrollment in Phase 3 clinical trial of Opaxio in ovarian cancer

Cell Therapeutics completes patient enrollment in Phase 3 clinical trial of Opaxio in ovarian cancer

Study: Taxol and Herceptin highly effective for lower-risk breast cancer patients

Study: Taxol and Herceptin highly effective for lower-risk breast cancer patients

Dog food preservative may prevent nerve damage in patients taking chemotherapy

Dog food preservative may prevent nerve damage in patients taking chemotherapy

TSRI scientists find new way to boost effectiveness of anticancer drugs

TSRI scientists find new way to boost effectiveness of anticancer drugs

Researchers reveal how SMIP004 anticancer compound targets prostate cancer cells

Researchers reveal how SMIP004 anticancer compound targets prostate cancer cells

Sorrento, IGDRASOL to present updates on IG-001 and IG-004 at joint meeting of CLINAM and ETPN

Sorrento, IGDRASOL to present updates on IG-001 and IG-004 at joint meeting of CLINAM and ETPN

Sorrento Therapeutics, IGDRASOL announce publication of clinical data for Cynviloq and gemcitabine

Sorrento Therapeutics, IGDRASOL announce publication of clinical data for Cynviloq and gemcitabine

Researchers demonstrate how EGF accelerates division of cell nucleus

Researchers demonstrate how EGF accelerates division of cell nucleus

Sorrento Therapeutics, IGDRASOL to present updates on Cynviloq at Nanomedicine 2013 meeting

Sorrento Therapeutics, IGDRASOL to present updates on Cynviloq at Nanomedicine 2013 meeting

IGDRASOL to present updates on Cynviloq at AACR annual meeting

IGDRASOL to present updates on Cynviloq at AACR annual meeting

DSMB recommends continuation of CTI’s OPAXIO Phase 3 trial on ovarian cancer

DSMB recommends continuation of CTI’s OPAXIO Phase 3 trial on ovarian cancer

NeuroVive announce results from CicloMulsion Phase I trial on cardiac reperfusion injury

NeuroVive announce results from CicloMulsion Phase I trial on cardiac reperfusion injury

EPO grants patent to Rexahn’s new isoquinolinamine compounds for cancer

EPO grants patent to Rexahn’s new isoquinolinamine compounds for cancer